Yahoo
ASX - Delayed Quote AUD

Vita Life Sciences Limited (VLS.AX)

2.7400 0.0000 (0.00%)
At close: October 29 at 4:10:12 PM GMT+11
Chart Range Bar
Loading chart for VLS.AX
  • Previous Close 2.7400
  • Open 2.8000
  • Bid 2.7400 x --
  • Ask 2.8000 x --
  • Day's Range 2.7400 - 2.8000
  • 52 Week Range 2.2700 - 2.9000
  • Volume 23,031
  • Avg. Volume 15,926
  • Market Cap (intraday) 147.696M
  • Beta (5Y Monthly) 0.53
  • PE Ratio (TTM) 13.70
  • EPS (TTM) 0.2000
  • Earnings Date (est.) --
  • Forward Dividend & Yield 0.15 (5.29%)
  • Ex-Dividend Date Sep 18, 2026
  • 1y Target Est --

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Mascot, Australia.

vitalifesciences.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

VLS.AX
12.31%
S&P/ASX 200 [XJO] (^AXJO)
2.22%

1-Year Return

VLS.AX
20.74%
S&P/ASX 200 [XJO] (^AXJO)
0.29%

3-Year Return

VLS.AX
80.64%
S&P/ASX 200 [XJO] (^AXJO)
31.37%

5-Year Return

VLS.AX
80.14%
S&P/ASX 200 [XJO] (^AXJO)
21.63%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.61%

  • Return on Assets (ttm)

    12.34%

  • Return on Equity (ttm)

    20.58%

  • Revenue (ttm)

    96.03M

  • Net Income Avi to Common (ttm)

    11.15M

  • Diluted EPS (ttm)

    0.2000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    33.7M

  • Total Debt/Equity (mrq)

    3.87%

  • Levered Free Cash Flow (ttm)

    12.5M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: